On Wednesday, Shares of Berry Plastics Group, Inc. (NYSE:BERY), dropped -2.82% to $33.73.
Berry Plastics Group, will report its second quarter fiscal 2015 results on Friday, May 1, 2015, before trading starts on the New York Stock Exchange. At 10 a.m. Eastern Time on that day, Berry Plastics will hold its regular quarterly conference call on the Company’s results and performance.
Berry Plastics Group, Inc. manufactures and distributes plastic consumer packaging and engineered materials in North America and internationally. The company operates through four segments: Rigid Open Top, Rigid Closed Top, Engineered Materials, and Flexible Packaging.
Shares of BioMed Realty Trust Inc. (NYSE:BMR), declined -2.81% to $20.76, during its last trading session.
BioMed Realty Trust, stated funds from operations (FFO) and core FFO (CFFO) per diluted share of $0.41 for the first quarter ended March 31, 2015, driven by over three million square feet of gross leasing over the past four quarters.
First Quarter Highlights
- Demand throughout the company’s vibrant core innovation districts generated 780,800 square feet of gross leases during the quarter, counting nearly 700,000 square feet of new leases as tenant relationships were formed or expanded with Biogen at 301 Binney Street in Cambridge, Massachusetts; Penn Presbyterian Medical Center at 3737 Market Street in Philadelphia; Stanford Health Care and Advanced Cell Diagnostics at the Pacific Research Center campus in the San Francisco Bay Area; Akamai Technologies and Reed Elsevier at 50 Hampshire Street in Cambridge, Massachusetts; and Juno Therapeutics at 217th Place in the Seattle market.
- The company grew its footprint in the South Lake Union submarket with the acquisition of the 307 Westlake Avenue North building for about $90 million. The property comprises 116,200 square feet of laboratory and office space which is 99% leased to four tenants, counting about 84,800 square feet to Seattle Biomedical Research Institute. Located in close proximity to the BioMed Realty Research Center, which comprises an existing 101,000 square foot building and a 123,000 square foot building under construction, the company owns nearly 500,000 square feet of life science research space in the core innovation districts of downtown Seattle.
- The company recaptured 313,000 square feet of space in three buildings in Cambridge, Massachusetts by terminating certain leases with Vertex Pharmaceuticals. The company received a $14 million termination payment and right away commenced redevelopment of the Sidney Street and 40 Erie Street properties to meet the growing demand for lab space in this dynamic market.
- Net gains totaling $11.0 million from the sale of equity investments in life science companies in the first quarter, with additional net gains totaling $43.8 million from the sale of an equity investment in a single life science company subsequent to the end of the quarter.
- The company strengthened its executive leadership team with the promotions of John Bonanno to Executive Vice President, Development and Investments and Jonathan Klassen to Executive Vice President and General Counsel.
BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. Its tenants primarily comprise biotechnology and pharmaceutical companies, scientific research institutions, government agencies, and other entities involved in the life science industry.
At the end of Wednesday’s trade, Shares of Con-way Inc. (NYSE:CNW), dwindled -2.77% to $42.50.
Con-way, will host a live webcast to talk about the results of the first quarter 2015, to be held Thursday, April 30, 2015 at 8:30 AM Eastern Time.
Con-way Inc., together with its auxiliaries, provides transportation, logistics, and supply chain administration services to various manufacturing, industrial, and retail customers in North America and internationally. It operates through three segments: Freight, Logistics, and Truckload.
Finally, Simon Property Group Inc. (NYSE:SPG), ended its last trade with -2.74% loss, and closed at $183.10.
Simon Property Group, stated results for the quarter ended March 31, 2015.
Results for the Quarter
Funds from Operations was $830.7 million, or $2.28 per diluted share, as contrast to $865.3 million, or $2.38 per diluted share, in the preceding year period. Results for the three months ended March 31, 2014 comprised of FFO per diluted share of $0.24 from the Washington Prime Group Inc. properties that were spun-off effective May 28, 2014. On a comparable basis, FFO per diluted share was $2.28 in the first quarter of 2015 as contrast to $2.14 in the first quarter of 2014.
Net income attributable to common stockholders was $362.2 million, or $1.16 per diluted share, as contrast to $341.6 million, or $1.10 per diluted share, in the preceding year period. On a comparable basis, net income per diluted share was $1.16 in the first quarter of 2015 as contrast to $0.99 in the first quarter of 2014.
Simon Property Group, Inc. is an equity real estate investment trust. The firm invests in the real estate markets across the globe. It engages in investment, ownership, administration, and development of properties.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.